AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home iRADIOLOGY Article
PDF (1.5 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Article | Open Access

Diagnostic Performance of Baseline FDG‐PET/CT for Detecting Bone Marrow Involvement in Classic Follicular Lymphoma

Haoying Huang Yingying ZhangJiajia DongYeye ZhouJihui LiXin XuNa Dai( )Bin Zhang( )
Department of Nuclear Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China
Show Author Information

Abstract

Background

Bone marrow involvement (BMI) is a key determinant of treatment strategies and clinical prognosis in classic follicular lymphoma (cFL). The diagnostic performance of baseline positron emission tomography/computed tomography (PET/CT) for identifying BMI remains unclear, and its consistency with bone marrow biopsy (BMB) results varies greatly across studies. Such diagnostic uncertainty hinders accurate clinical risk stratification. This study aimed to assess the diagnostic performance of PET/CT and explore associated diagnostic risk factors.

Methods

A total of 176 patients with newly diagnosed classic follicular lymphoma were included. Clinical data, hematological parameters, and PET imaging findings were recorded for all patients and compared with the BMB report. Univariate and multivariate analyses were performed to identify risk factors associated with BMB‐confirmed BMI, and corresponding receiver operating characteristic (ROC) curves were plotted to evaluate their diagnostic efficacy.

Results

Taking BMB as the reference standard for detecting BMI, sensitivity and specificity of PET/CT were 57.9% and 70.0%. PET/CT‐derived BMI (p = 0.023), bulky mass (> 6 cm) (p < 0.001), and spleen involvement (p < 0.001) were identified as independent risk factors for BMB‐confirmed BMI with the diagnostic performance (AUC) as 0.639 (p = 0.002), 0.635 (p = 0.002), and 0.702 (p < 0.001), respectively. Furthermore, the combined diagnostic performance of these three factors reached 0.788 (p < 0.001).

Conclusions

Baseline PET/CT provides critical insights into the assessment of BMI in cFL. For patients with PET/CT images of focal with or without diffuse components, BMB may yield false‐negative results due to sampling limitations. For patients with a diffuse component, the presence of bulky disease and spleen involvement is strongly predictive of BMB‐confirmed BMI. Conversely, the absence of PET/CT‐detected BMI, bulky disease, and splenic involvement suggests a low likelihood of BMB‐confirmed BMI.

Graphical Abstract

References

【1】
【1】
 
 
iRADIOLOGY
Pages 273-280

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Huang H, Zhang Y, Dong J, et al. Diagnostic Performance of Baseline FDG‐PET/CT for Detecting Bone Marrow Involvement in Classic Follicular Lymphoma. iRADIOLOGY, 2026, 4(3): 273-280. https://doi.org/10.1002/ird3.70082

7

Views

0

Downloads

0

Crossref

0

Web of Science

0

Scopus

Received: 12 April 2026
Revised: 26 May 2026
Accepted: 26 May 2026
Published: 11 June 2026
© 2026 The Author(s). Tsinghua University Press.

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.